| 1. | Peggy N, Brubaker L. Urinary incontinence in women. Lancet, 2006, 367(9504): 57-67. | 
				                                                        
				                                                            
				                                                                | 2. | Hampel C, Wienhold D, Benken N, et al. Prevalence and natural history of female incontinence. Eur Urol, 1997, 32 Suppl 2: 3-12. | 
				                                                        
				                                                            
				                                                                | 3. | Bump RC, Norton PA. Epidemiology and natural history of pelvic fioor dysfunction. Obstet Gynecol Clin North Am, 1998, 25(4): 723-746. | 
				                                                        
				                                                            
				                                                                | 4. | Strasser H, Berjukow S, Marksteiner R, et al. Stem cell therapy for urinary stress incontinence. Exp Gerontol, 2004, 39(9): 1259-1265.. | 
				                                                        
				                                                            
				                                                                | 5. | 韓平, 解慧琪, 羅靜聰, 等. 細胞治療臨床應用新進展. 中國修復重建外科雜志, 2008, 22(2): 221-227. | 
				                                                        
				                                                            
				                                                                | 6. | Bhatia NN, Ho MH. Stem cell therapy for urinary incontinence and pelvic floor disorders: a novel approach. Curr Opin Obstet Gynecol, 2004, 16(5): 397-398.. | 
				                                                        
				                                                            
				                                                                | 7. | Corcos J, Loutochin O, Campeau L, et al. Bone marrow mesenchymal stromal cell therapy for External urethral sphincter restoration in a rat model of stress urinary incontinence. Neurourol Urodyn, 2011, 30(3): 447-455. | 
				                                                        
				                                                            
				                                                                | 8. | Kim SO, Na HS, Kwon D, et al. Bone-marrow-derived Mese nc hymal stem cell transplantation enhances closing pressure and leak point pressure in a female urinary incontinence rat model. Urol Int, 2011, 86(1): 110-116. | 
				                                                        
				                                                            
				                                                                | 9. | Kinebuchi Y, Aizawa N, Imamura T, et al. Autologous bone-marrow-derived mesenchymal stem cell transplantation into injured rat urethral sphincter. Int J Urol, 2010, 17(4): 359-368. | 
				                                                        
				                                                            
				                                                                | 10. | Imamura T, Ishizuka O, Kinebuchi Y, et al. Implantation of autologous bone-marrow-derived cells Reconstructs functional urethral sphincters in rabbits. Tissue Eng Part a, 2011, 17(7-8): 1069-1081. | 
				                                                        
				                                                            
				                                                                | 11. | Strasser H, Marksteiner R, Margreiter E, et al. Transurethral ultrasound guided injection of clonally cultured autologous myoblasts and fibroblasts: experimental results. J Urol, 2003, 169: 39. | 
				                                                        
				                                                            
				                                                                | 12. | Lee JY, Cannon TW, Pruchnic R, et al. The effects of periurethral muscle-derived stem cell injection on leak point pressure in a rat model of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct, 2003, 14(1): 31-37. | 
				                                                        
				                                                            
				                                                                | 13. | Gimble JM. Adipose tissue-derived therapeutics. Expert Opin Biol Ther, 2003, 3(5): 705-713. | 
				                                                        
				                                                            
				                                                                | 14. | Wu G, Zheng X, Jiang Z, et al. Induced differentiation of adipose-derived stromal cells into myoblasts. J Huazhong Univ Sci Technol, 2010, 30(3): 285-290. | 
				                                                        
				                                                            
				                                                                | 15. | Forraz N, Mcguckin CP. The umbilical cord: a rich and ethical stem cell source to advance regenerative medicine. Cell Prolif, 2011, 44(Suppl 1): 60-69. | 
				                                                        
				                                                            
				                                                                | 16. | Chermansky CJ, Tarin T, Kwon DD, et al. Intraurethral muscle-derived cell injections increase leak point pressure in a rat model of intrinsic sphincter deficiency. Urology, 2004, 63(4): 780-785. | 
				                                                        
				                                                            
				                                                                | 17. | Lim JJ, Jang JB, Kim JY, et al. Human umbilical cord blood mononuclear cell transplantation in rats with intrinsic sphin cter deficiency. J Korean Med Sci, 2010, 25(5): 663-670. | 
				                                                        
				                                                            
				                                                                | 18. | Carr LK, Steele D, Steele S, et al. 1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct, 2008, 19(6): 881-883. | 
				                                                        
				                                                            
				                                                                | 19. | Lee CN, Jang JB, Kim JY, et al. Human cord blood stem cell therapy for treatment of stress urinary incontinence. J Korean Med Sci, 2010, 25(6): 813-816. | 
				                                                        
				                                                            
				                                                                | 20. | Atala A, Cima LG, Kim W, et al. Injectable alginate seeded with chondrocytes as a potential treatment for vesicoureteral reflux. J Urol, 1993, 150(2 Pt 2): 745-747.. | 
				                                                        
				                                                            
				                                                                | 21. | Atala A, Kim W, Paige KT, et al. Endoscopic treatment of vesicoureteral reflux with a chondrocyte-alginate suspension. J Urol, 1994, 152(2 Pt 2): 641-643. | 
				                                                        
				                                                            
				                                                                | 22. | Bent AE, Tutrone RT, McLennan MT, et al. Treatment of intrinsic sphincter deficiency using autologous ear chond rocytes as a bulking agent. Neurourol Urodyn, 2001, 20(2): 157-165. | 
				                                                        
				                                                            
				                                                                | 23. | Vandenburgh H, Del TM, Shansky J, et al. Tissue-engineered skeletal muscle organoids for reversible gene therapy. Hum Gene Ther, 1996, 7(17): 2195-2200. | 
				                                                        
				                                                            
				                                                                | 24. | Chancellor MB, Yokoyama T, Tirney S, et al. Preliminary results of myoblast injection into the urethra and bladder wall: a possible method for the treatment of stress urinary incontin ence and impaired detrusor contractility. Neurourol Urodyn, 2000, 19(3): 279-287. | 
				                                                        
				                                                            
				                                                                | 25. | Wakitani S, Saito T, Caplan AI. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve, 1995, 18(12): 1417-1426. | 
				                                                        
				                                                            
				                                                                | 26. | Strasser H, Berjukow S, Marksteiner R, et al. Stem cell therapy for urinary stress incontinence. Exp Gerontol, 2004, 39(9): 1259-1265. | 
				                                                        
				                                                            
				                                                                | 27. | Fu Q, Song XF, G, Liao GL, et al. Myoblasts differentiated from adipose-derived stem cells to treat stress urinary incontinence. Urology, 2010, 75(2): 718-723. | 
				                                                        
				                                                            
				                                                                | 28. | Lee OK, Kuo TK, Chen WM, et al. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood, 2004, 103(5): 1669-1675. | 
				                                                        
				                                                            
				                                                                | 29. | Sarugaser R, Lickorish D, Baksh D, et al. Human umbilical cord perivascular(hucpv)cells: a source of mesenchymal progenitors. Stem Cells, 2005, 23(2): 220-229. | 
				                                                        
				                                                            
				                                                                | 30. | Kaviani A, Perry TE, Dzakovic A, et al. The amniotic fluid as a source of cells for fetal tissue engineering. J Pediatr Surg, 2001, 36(11): 1662-1665. | 
				                                                        
				                                                            
				                                                                | 31. | Bilic G, Zeisberger SM, Mallik AS, et al. Comparative characterization of cultured human term amnion epithelial and mesenchymal stromal cells for application in cell therapy. Cell Transplant, 2008, 17(8): 955-968. | 
				                                                        
				                                                            
				                                                                | 32. | Portmann-Lanz PC, Andreina S, Huber A, et al. Placental mesenchymal stem cells as potential autologous graft for pre-and perinatal neuroregeneration. Am J Obstet Gynecol, 2006, 194(3): 664-673. |